AU2002237287A1 - Targets and therapeutic agents for the treatmnt of epstein-barr virus infection - Google Patents

Targets and therapeutic agents for the treatmnt of epstein-barr virus infection

Info

Publication number
AU2002237287A1
AU2002237287A1 AU2002237287A AU2002237287A AU2002237287A1 AU 2002237287 A1 AU2002237287 A1 AU 2002237287A1 AU 2002237287 A AU2002237287 A AU 2002237287A AU 2002237287 A AU2002237287 A AU 2002237287A AU 2002237287 A1 AU2002237287 A1 AU 2002237287A1
Authority
AU
Australia
Prior art keywords
treatmnt
epstein
targets
therapeutic agents
virus infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002237287A
Inventor
Georg Bornkamm
Igor Ivanov
Bettina Kempkes
Andreas Machl
Maja Santak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Agennix AG
Original Assignee
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Agennix AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH, Agennix AG filed Critical Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Publication of AU2002237287A1 publication Critical patent/AU2002237287A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/05—Epstein-Barr virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
AU2002237287A 2001-01-23 2002-01-23 Targets and therapeutic agents for the treatmnt of epstein-barr virus infection Abandoned AU2002237287A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01101452.9 2001-01-23
EP01101452 2001-01-23
PCT/EP2002/000659 WO2002059606A2 (en) 2001-01-23 2002-01-23 Targets and therapeutic agents for the treatmnt of epstein-barr virus infection

Publications (1)

Publication Number Publication Date
AU2002237287A1 true AU2002237287A1 (en) 2002-08-06

Family

ID=8176276

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002237287A Abandoned AU2002237287A1 (en) 2001-01-23 2002-01-23 Targets and therapeutic agents for the treatmnt of epstein-barr virus infection

Country Status (2)

Country Link
AU (1) AU2002237287A1 (en)
WO (1) WO2002059606A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102660469A (en) * 2012-05-31 2012-09-12 哈尔滨工业大学 Constructing method for pichia genetic engineering strain for expressing plant resistance-inducing factors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2587795A (en) * 1994-05-20 1995-12-18 Tularik Inc. Epstein-barr virus transcription factor binding assay
WO1996020723A1 (en) * 1994-12-30 1996-07-11 Brigham & Women's Hospital Controlling traf-mediated signals
WO1997030081A1 (en) * 1996-02-13 1997-08-21 The Johns Hopkins University School Of Medicine Ebna2 peptides and methods of using same

Also Published As

Publication number Publication date
WO2002059606A2 (en) 2002-08-01
WO2002059606A3 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
AP2001002301A0 (en) Inhibition of viral infection using monovalentantigen-binding proteins
EP1446121A4 (en) Diindolylmethane for the treatment of hpv infection
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU2281601A (en) Treatment of viral infections using levovirinTM
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
AU2001269092A1 (en) Inhibitors of hepatitis b virus infection
AP2002002432A0 (en) Treatment of viral infections
AU2002237287A1 (en) Targets and therapeutic agents for the treatmnt of epstein-barr virus infection
AU2002332613A1 (en) Compositions and therapeutic methods for viral infection
AU2002323443A1 (en) Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
AU2002327531A1 (en) Therapeutic compositions and methods for treating viral infection
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
AU3524700A (en) Prevention and treatment of viral infections
AU2001264856A1 (en) Inhibitors of viral infection
AU2002336305B2 (en) Preventive and/or therapeutic agent for viral infection
AU2003299493A1 (en) Compositions and methods for the treatment of hepatitis c virus infection
AU2002336305A1 (en) Preventive and/or therapeutic agent for viral infection
AU2002237845A1 (en) Thioxazinoquinolones useful for the treatment of viral infections
AU4024400A (en) Composition and methods for the treatment of cancer and viral infections
AUPR723301A0 (en) Device for treatment of viral infection
AU2002255937A1 (en) Methods for the treatment of hiv and other viruses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase